Neoadjuvant Therapy for cT2N0M0 Rectal Cancer?

被引:1
|
作者
Rubio, Gustavo A. [1 ]
Hurst, Roger D. [1 ]
Umanskiy, Konstantin [1 ]
Shogan, Benjamin D. [1 ]
Hyman, Neil [1 ]
Olortegui, Kinga Skowron [1 ]
机构
[1] UChicago Med, Dept Surg, Sect Colon & Rectal Surg, 5841 S Maryland Ave,MC 5095,S217, Chicago, IL 60637 USA
关键词
Early-stage rectal cancer; Neoadjuvant chemoradiation; cT2N0M0; Total neoadjuvant therapy; Clinical staging;
D O I
10.1007/s11605-021-05125-8
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:479 / 482
页数:4
相关论文
共 50 条
  • [31] Organ Preservation in cT2N0 Rectal Cancer After Neoadjuvant Chemoradiation Therapy The Impact of Radiation Therapy Dose-escalation and Consolidation Chemotherapy
    Habr-Gama, Angelita
    Sao Juliao, Guilherme Pagin
    Vailati, Bruna Borba
    Sabbaga, Jorge
    Aguilar, Patricia Bailao
    Fernandez, Laura Melina
    Alonso Araujo, Sergio Eduardo
    Perez, Rodrigo Oliva
    ANNALS OF SURGERY, 2019, 269 (01) : 102 - 107
  • [32] Downstaged ypT0-2N0 rectal cancer after neoadjuvant chemoradiation therapy may not need adjuvant chemotherapy: a retrospective cohort study
    Yu-Tso Liao
    Yu-Lin Lin
    John Huang
    Ji-Shiang Hung
    Been-Ren Lin
    International Journal of Colorectal Disease, 2021, 36 : 509 - 516
  • [33] Downstaged ypT0-2N0 rectal cancer after neoadjuvant chemoradiation therapy may not need adjuvant chemotherapy: a retrospective cohort study
    Liao, Yu-Tso
    Lin, Yu-Lin
    Huang, John
    Hung, Ji-Shiang
    Lin, Been-Ren
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2021, 36 (03) : 509 - 516
  • [34] T3 N1 M0 rectal cancer: optimal initial management is total neoadjuvant therapy
    Nilsson, Per J.
    BRITISH JOURNAL OF SURGERY, 2024, 111 (01)
  • [35] Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after neoadjuvant chemoradiation therapy.
    Kim, Chang-gon
    Jung, Minkyu
    Jung, Inkyung
    Shin, Sang Joon
    Beom, Seung Hoon
    Kim, Joo Hoon
    Heo, Su Jin
    Kim, Ji Hyung
    Koom, Woong Sub
    Hur, Hyuk
    Min, Byung Soh
    Kim, Nam Kyu
    Kim, Ho Geun
    Ahn, Joong Bae
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [36] A nomogram for predicting cancer specific survival (CSS) in patients with pathological T3N0M0 (pT3N0M0) rectal cancer
    Liu, Shuang
    Xi, ShaoYan
    Wu, Xiao-Jun
    Cai, Peiqiang
    Ding, Pei-Rong
    Chen, Gong
    Pan, Zhi-Zhong
    Gao, Yuan-Hong
    Xiao, Weiwei
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [37] Is adjuvant chemotherapy necessary for patients with ypT0-2N0 rectal cancer treated with neoadjuvant chemoradiotherapy and curative surgery?
    Lu, Zhao
    Cheng, Pu
    Zhang, Ming-Guang
    Wang, Xi-Shan
    Zheng, Zhao-Xu
    GASTROENTEROLOGY REPORT, 2018, 6 (04): : 277 - 283
  • [38] T2N0M0 esophageal cancer
    Rice, Thomas W.
    Mason, David P.
    Murthy, Sudish C.
    Zuccaro, Gregory, Jr.
    Adelstein, David J.
    Rybicki, Lisa A.
    Blackstone, Eugene H.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2007, 133 (02): : 317 - U1
  • [39] The prognostic impact of preoperative blood monocyte count in pathological T3N0M0 rectal cancer without neoadjuvant chemoradiotherapy
    Zhang, Lu-Ning
    Xiao, Weiwei
    OuYang, Pu-Yun
    You, Kaiyun
    Zeng, Zhi-Fan
    Ding, Pei-Rong
    Pan, Zhi-Zhong
    Xu, Rui-Hua
    Gao, Yuan-Hong
    TUMOR BIOLOGY, 2015, 36 (10) : 8213 - 8219
  • [40] Transanal endolaparoscopic resection of T2N0M0 low rectal adenocarcinoma followed by adjuvant therapy
    Dapri, G.
    Bascombe, N. A.
    Soloviy, M.
    Kouatang, A.
    Mena, C. Martinez
    COLORECTAL DISEASE, 2019, 21 (08) : 970 - 971